Corneal diameter negatively associated with central corneal thickness

Article

Corneas in microphthalmic eyes have significantly higher central corneal thickness (CCT) regardless of whether or not the patient underwent congenital cataract surgery.

Corneas in microphthalmic eyes have significantly higher central corneal thickness (CCT) regardless of whether or not the patient underwent congenital cataract surgery, according to a study published in the European Journal of Ophthalmology.

The investigation by Dr Ales Filous et al., Department of Ophthalmology for Children and Adults, Charles University, Prague, Czech Republic, involved 32 patients post-congenital cataract surgery with absolute microcornea (Group A), 13 patients with absolute microcornea without any history of eye surgery (Group B) and a control group of 124 healthy schoolchildren.

Patients with scars or corneal oedema were excluded from the study. Horizontal corneal diameter (HCD) was measured with calliper and CCT was recorded using an ultrasound pachymeter.

The findings demonstrated a significantly higher CCT of 635.13±65.35 µm and 642.31±93.07 µm, respectively in 48 eyes from group A and 16 eyes in Group B. This was compared to the mean CCT in the control group of 553.58±33.12 µm. A decrease in HCD and an increase in CCT were demonstrated by the regression curve in the microphthalmic eyes.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.